Irving, TX (PRWEB) November 30, 2015
Thermi™, a world leader in thermistor-regulated energy solutions for plastic surgery and dermatology, is proud to announce that its ThermiRFR temperature controlled radiofrequency platform has received CE marking and may now be sold in Europe.
ThermiRF is an innovative multi-application radiofrequency platform which uses temperature as a clinical endpoint. The technology has been available in the United States and Asia since 2012 and is finally entering the European marketplace. The company plans its initial launch activities to be held in Hamburg, Germany in December.
Since its introduction in the US market in 2012, over 40,000 procedures have been performed with the popular ThermiRF platform. ThermiRF applications are based on numerous peer-reviewed protocols. ThermiRaseR uses a tiny subdermal probe which applies heat disable motor nerves which cause unwanted glabella furrows (brow) and platysma banding (neck). ThermiTightR is a single treatment for laxity which uses a tiny RF probe which is inserted under the skin using local anesthesia. Tissues are heated to a user-selected temperature which causes shrinkage of collagen and destruction of fat cells. ThermiVa uses a proprietary disposable hand piece for non-surgical feminine rejuvenation. ThermiVa treatments target issues common with child bearing and menopause. A recent study showed benefits for women suffering from vaginal laxity, vaginal atrophy (dryness), incontinence, overactive bladder and compromised sensation.
According to company CEO, Paul Herchman, “We are pleased to finally enter the European market with our ThermiRF and Thermi250 platforms. We have seen strong interest in our solutions in the Eurozone and we expect Thermi to become a leader in Europe very quickly.”
About Thermi. Thermi is a leading manufacturer of thermistor-regulated solutions for the aesthetic and gynecologic markets. With three platforms – ThermiRF, ThermiVa and Thermi250, plastic surgeons, dermatologists and cosmetic physicians offer a wide array of solutions for patients using “the science of heat” where temperature is the clinical endpoint. The company’s products are distributed worldwide.
For more information please visit: http://www.thermi.com/
EDITOR'S NOTE: For more information about ThermiRF and to arrange to speak with a company spokesperson, please contact Nancy Trent or Pamela Wadler at 212-966-0024 or pam(at)trentandcompany(dot)com.